A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

NCT01640080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Esketamine
DRUG: Esketamine
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC